You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 14, 2025

Details for Patent: 11,103,463


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,103,463
Title:Methods for treating alzheimer's disease with donepezil transdermal system
Abstract: A transdermal delivery system for systemic delivery of donepezil is described, where the system comprises an adhesive matrix drug reservoir layer comprised of a copolymer of acrylic acid/vinyl acetate, triethyl citrate, and donepezil base generated in situ by reaction of donepezil HCl and an alkaline salt. The system is provided for treatment of Alzheimer's disease, and achieves transdermal delivery of the therapeutic agent at steady state that is bioequivalent to administration of the therapeutic agent orally.
Inventor(s): Lee; Eun Soo (Redwood City, CA), Jain; Amit K. (Milpitas, CA), Singh; Parminder (Union City, CA)
Assignee: Corium, Inc. (Grand Rapids, MI)
Application Number:16/392,513
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,103,463: A Detailed Analysis

Introduction

When analyzing a patent, particularly one like United States Patent 11,103,463, it is crucial to delve into the scope and claims to understand its implications and the broader patent landscape. This article will provide a comprehensive analysis, leveraging recent updates in patent law and best practices in patent searching and evaluation.

Patent Basics

Before diving into the specifics of the patent, it's essential to understand the basic components of a patent.

  • Patent Scope: This refers to the breadth and depth of protection granted by the patent. It is often measured by metrics such as independent claim length and count, which can indicate the patent's breadth and clarity[3].
  • Patent Claims: These are the legal definitions of the invention and define the scope of the protection. Claims can be independent or dependent and must be clear, concise, and fully supported by the patent's description[4].

The 2024 USPTO Guidance Update

Recent updates from the USPTO, particularly the 2024 guidance on AI patent eligibility, provide valuable insights into how patents are evaluated.

  • Subject Matter Eligibility: The update emphasizes the importance of integrating judicial exceptions into practical applications. This means that claims must show how abstract ideas are applied in a way that provides concrete benefits or solves specific problems in the relevant field[1].
  • AI-Assisted Inventions: The guidance clarifies that the use of AI in the development of an invention does not affect its subject matter eligibility. Instead, the focus is on the claimed invention itself and whether it offers significant human contribution and technological improvement[1].

Analyzing Patent 11,103,463

Patent Title and Abstract

To begin, the title and abstract of the patent provide a high-level overview of the invention. For example, if the patent is related to AI technology, the abstract would likely describe how the invention integrates AI into a practical application.

Claims Analysis

The claims section is critical as it defines the scope of the patent.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are crucial in determining the patent's scope and eligibility.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They often add specific details that can help in narrowing down the scope and ensuring the invention meets the criteria for patent eligibility[4].

Claim Examples

Using the 2024 USPTO guidance, let's consider an example similar to those provided in the update:

  • Claim 1: This might involve a general method of data processing using AI without specifying a practical application.
    • Analysis: Such a claim would likely be considered ineligible as it does not integrate the abstract idea into a practical application.
  • Claim 2: This could specify the use of the data processing method in a real-time speech recognition system to enhance the accuracy of voice commands.
    • Analysis: This claim would be more likely to be patent-eligible because it specifies a practical application that provides tangible benefits, such as improved accuracy in speech recognition systems[1].

Practical Applications and Technological Improvements

The practical application of the claimed invention is a key factor in determining its patent eligibility.

  • Real-World Benefits: The patent must demonstrate how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field. For example, if the patent involves AI in medical diagnostics, it must show how the AI improves diagnostic accuracy or patient outcomes[1].

Search and Examination Process

The process of searching and examining patents is crucial in ensuring the validity and scope of the patent.

  • Patent Public Search: Tools like the Patent Public Search and Global Dossier help in identifying prior art and related applications, ensuring that the patent does not overlap with existing inventions[4].
  • Examination Process: The examination process tends to narrow the scope of patent claims, making them more specific and reducing the likelihood of overly broad claims being granted[3].

International Patent Landscape

Understanding the international patent landscape is essential, especially for inventions with global implications.

  • International Patent Databases: Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) help in searching for prior art and related patents globally[4].

Legal and Policy Considerations

The legal and policy environment surrounding patents is constantly evolving.

  • Small Claims Patent Court: There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes are resolved, particularly for smaller inventors and businesses[2].

Key Takeaways

  • Subject Matter Eligibility: The integration of judicial exceptions into practical applications is crucial for patent eligibility.
  • AI-Assisted Inventions: AI's role as a tool does not exclude inventions from eligibility if there is significant human contribution and technological improvement.
  • Practical Applications: Demonstrating real-world benefits and solving specific problems in the relevant field is essential.
  • Search and Examination: Utilizing tools like Patent Public Search and Global Dossier, and understanding the examination process, helps in ensuring the validity and scope of the patent.

FAQs

  1. What is the significance of the 2024 USPTO guidance update on AI patent eligibility?

    • The update refines and clarifies the process for determining the patent eligibility of AI-related inventions, emphasizing the integration of judicial exceptions into practical applications and ensuring AI-assisted inventions are evaluated on equal footing with other technologies[1].
  2. How do independent and dependent claims differ in a patent?

    • Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to and further limit the independent claims, often adding specific details to narrow down the scope[4].
  3. What role does the examination process play in patent scope?

    • The examination process tends to narrow the scope of patent claims, making them more specific and reducing the likelihood of overly broad claims being granted[3].
  4. Why is it important to search international patent databases?

    • Searching international patent databases helps in identifying prior art and related patents globally, ensuring that the patent does not overlap with existing inventions and providing a comprehensive view of the patent landscape[4].
  5. What is the potential impact of a small claims patent court on patent disputes?

    • A small claims patent court could provide a more accessible and cost-effective way for smaller inventors and businesses to resolve patent disputes, potentially reducing the complexity and cost associated with traditional patent litigation[2].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility - Mintz.
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States.
  3. Patent Claims and Patent Scope - SSRN.
  4. Search for Patents - United States Patent and Trademark Office.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,103,463

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Corium ADLARITY donepezil hydrochloride SYSTEM;TRANSDERMAL 212304-001 Mar 11, 2022 RX Yes No ⤷  Try for Free ⤷  Try for Free A METHOD OF TRANSDERMAL DELIVERY OF DONEPEZIL FOR TREATING MILD, MODERATE AND SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE ⤷  Try for Free
Corium ADLARITY donepezil hydrochloride SYSTEM;TRANSDERMAL 212304-002 Mar 11, 2022 RX Yes Yes ⤷  Try for Free ⤷  Try for Free A METHOD OF TRANSDERMAL DELIVERY OF DONEPEZIL FOR TREATING MILD, MODERATE AND SEVERE DEMENTIA OF THE ALZHEIMER'S TYPE ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.